Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct:190:104081.
doi: 10.1016/j.critrevonc.2023.104081. Epub 2023 Aug 2.

Risk factors for developing both primary breast and primary ovarian cancer: A systematic review

Affiliations

Risk factors for developing both primary breast and primary ovarian cancer: A systematic review

Jennifer S Ferris et al. Crit Rev Oncol Hematol. 2023 Oct.

Abstract

Objective: Women with breast cancer have an increased risk of primary ovarian cancer (BR→OV), and women with ovarian cancer have an increased risk of primary breast cancer (OV→BR). This systematic review summarizes risk factors for developing BR→OV and OV→BR.

Methods: We searched PubMed and Embase until June 2022.

Results: We identified 23 articles meeting our inclusion criteria. Studies observed a lower risk of BR→OV for Black versus White women, alcohol consumption, radiotherapy and hormone therapy, BRCA2 versus BRCA1, and ER/PR positive versus negative breast tumors, and a higher risk with family history of breast/ovarian cancer, triple negative versus luminal breast cancer, and higher grade breast tumors. There was an increased risk of OV→BR with family history of cancer.

Conclusions: Tumor characteristics, and genetic and familial factors are associated with risk of BR→OV and OV→BR. These results could aid clinicians in decision-making for breast and ovarian cancer patients, including risk-reducing strategies.

Keywords: Breast cancer; Ovarian cancer; Risk Factors; Second cancers; Systematic Review.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Dr. Wright has received royalties from UpToDate and research support from Merck. All other authors have no conflicts of interest.

Publication types